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Wave-mixed bioreactors have increasingly replaced stainless steel stirred tank reactors in seed inoculum
productions and mammalian cell-based process developments. Pre-sterilized, single-use plastic bags are used for
cultivation, eliminating the risk of cross-contamination and cleaning procedures. However, these advantages
come with high consumable costs which is the main barrier to more uptakes of the technology by academic
institutions. As an academic Core Facility that faces high demand in protein production from insect cells, we have
therefore developed a cost-effective alternative to disposable wave bags. In our study we identified:
 A re-usable wave shaken polycarbonate bioreactor for protein production in insect cells achieves protein yields
comparable to disposable bags.
 The advantages of this re-usable bioreactor are low costs, long life cycle, flexible configuration of accessories
and convenient handling due to its rigid shape.
ã 2016 Max-Planck Institute of Biochemistry. Published by Elsevier B.V. This is an open access article under the CC
BY license (http://creativecommons.org/licenses/by/4.0/).
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1. As a cultivation container, a polycarbonate box 500 U Eurostandard Typ IV S, TECNIPLAST, Italy, Size
480  375  210 mm, Volume 38 L, originally made for animal housing was used. The material is
transparent and autoclavable repeatedly at 121 C. The 1st Cooper model was autoclaved and used
35 times without loss of performance.
. The lid was constructed in-house. It consists of polycarbonate at corresponding size and is sealed
with a layer of rubber foam. Six metal clamps on four sides guarantee tight attachment to the base
container.
. Within the lid, seven ports with connectors to both inner and outer sides are inserted. These
insertions are screw threads manufactured in-house.
a. Two openings are standard 13.5 Pg ports for optional pH or pO2 sensors (not used in our settings).
b. One single wide-mouth opening of 5.4 cm inner diameter serves as air outlet, covered with
C55 Silicon Cap (Hirschmann, VWR, Cat No 8905755) and protected by aluminium foil during
autoclaving.
Another four ports (one wildcard) at inner diameter of 0.5 cm have been introduced for
c. Air inlet, sterile filtered through an Acro 50, 0.2 mm PTFE filter, (Pall, P/N 4151), also covered by
aluminium foil for autoclaving.
d. Aseptic sampling with Super Safe Sampler (Infors, Cat No 65373) and thin inside tubing (ID
2 mm, OD 4 mm), that allows to take smallest sample volumes without any risk of introducing
contaminations.
e. Medium fill via a long (outside 2.30 m, inside 24 cm) tubing, connected via stainless steel quick
connectors (Stäubli, Cat No RBE06.1806/IC/OD/JE, RBE06.7806/IC/JE) to a 1 L Schott bottle,
pressure balanced by an Acrodisc CR 0,45 mm PTFE sterile filter (Pall) for autoclaving.
. Pharma-compliant platinum cured silicone tubings (Applied Critical Fluids, Cat No I-SA P60 40-24-
88, ID 4.0, OD 8.8; Wall 2.4 mm) were used. The tubings are suitable for peristaltic pumps and
autoclavable.
. Bioreactor and connected Schott Bottle are sterilized by autoclaving (121 C, 15 C, 20 min). After
sterilization, the Schott bottle can be replaced by the medium reservoir or starting culture eg. in a
2 L bottle to be pumped into the reactor. This port can also be used for fed-batch during cultivation.
mall and large scale insect cell culture protocols
1. Sf9 (Life Technologies) or Hi5 cells (provided by Gene Center, LMU Munich) were grown in
suspension in Ex-Cell 420 (Sigma, Cat No 24420C). Cell count, viability and cell diameter were
analyzed using the Vi-cell XR cell counter (Beckman Coulter). Cells were maintained at a density 1–
5 106 cells/mL and 0.2–5 106 cells/mL for Sf9 and Hi5 cells respectively. Cell diameter is about
19 mm, and viability should be higher than 95%. It is important to ensure that cells are
approximately those values in order to maintain high quality and reproducibility of experiments.
. Cells were grown in shaker incubators (Infors, 50 mm rotating diameter) at 27 C in Erlenmeyer EM
or Fernbach FB glass flasks covered with Silicon Caps (Hirschmann, VWR) at the following
combinations of culture volume  flask volume  shaking speed: 30 mL  250 mL EM  120 rpm;
150 mL  1 L EM  120 rpm; 200 to 400 mL  1,8L FB  90 rpm; 400 mL to 1 L  5 L EM  90 rpm
. Baculovirus expression was performed according to the Bac-to-Bac1 protocol (Life Technologies).
Bacmid transfections in Sf9 cells were harvested after 3–5 days. Virus titer was determined using
the SF9-ET easy titer cell line [1]. Virus was either amplified in two subsequent steps to generate
Passage 1 and Passage 2 virus stocks or used to generate Baculo Infected Insect Cells (BIIC) as
described previously [2]. BIICs frozen at 80 C served both for protein expression and as virus
storage. For protein expression, Hi5 and SF9 cells were adjusted to 1 106 cells/mL and infected
with virus stock or BIICs at different dilutions, typically in the range 1:1000–1:10,000.
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Method validation
For protein production at 1 L scale we are using 5 L Erlenmeyer glass flasks (modified in shape, see
Fig. 1) and have also tested Thomson Optimum Growth Flasks (Cat No 931116) filled with 2 L culture
volume. In order to evaluate the upscale to 5 and 10 L, protein expression was first compared between
flasks, Wave disposable Bags (GE Healthcare, Cat No CB0010L10-01), and the newly developed
bioreactor, named Cooper. Both containers were shaken on a Wave System 20/50 EH. Parameters
previously optimized at small scale were: temperature 26 C; production time 72 h; cell density at
infection 1 106 cells/mL. The optimal rocking rates and angles were optimized individually for both
bioreactors based on cell viability and productivity of a target protein Zyx-LIM-eGFP. For Wave Bags, a
rocking rate and angle of 28 rpm and 9 respectively, were recommended by the manufacturer and
resulted in best productivity (Table 1). For the Cooper bioreactor, the rocking rate and angle were
adapted to achieve a fluid wave comparable to the Wave Bag as well as maximal cell viability and Zyx-
LIM-eGFP productivity. The resulting parameters were 30 rpm and 7,5. In summary, productivity of
Zyx-LIM-eGFP was comparable in all cultivation containers tested as shown in Table 1.
Encouraged by the results, productivity at 5 L scale in Wave Bags versus Cooper Bioreactor for three
more proteins was compared next. Protein yield, concentration and purity in the re-usable bioreactor
were comparable in Cooper and Wave Bags (Table 2 and Fig. 2). Comparisons of cell parameters at
harvest show higher cell viability in three out of four Wave Bag productions. Despite having omitted
any antifoam reagent in the ExCell 420 medium, no foaming was observed in both bioreactors, as
illustrated in the Graphical Abstract showing Zyx-LIM-eGFP production in the Cooper bioreactor.
Additional information
Space is rapidly becoming limited when scaling up insect cell suspension cultures for production.
One Infors shaker can accommodate 6  5 L Erlenmeyers flasks, giving 6 L production capacity. There
are different solutions to that space limitation, the choice of which depends very much on the
individual equipment available. Most common are bioreactors especially in the pharmaceutical
industry, albeit less represented in academic laboratories. In the past few years, alternative choices
have emerged, like high cell density protocols [4] or culture vessels that can be filled up to 5 L [5].
Having Labfors stirred-tank bioreactors and Wave Platforms available, we invested efforts in
bioreactor cultivation.
Fig. 1. Protein production in 5 L Erlenmeyer, Thomson Flasks and Fernbach Flasks.
















5Upscale to 5 L was first performed in a stirred-tank bioreactor (Labfors, Infors, 7.5 L) adapted to
nsect-cell cultivation with integrated pH and pO2 measurement and regulation. Expression levels
ere comparable to flask expression (data not shown). Most interestingly was the fact that pH and pO2
as very stable throughout the entire cultivation and protein production process and did not need any
orrection. As a consequence, the rather labor-intensive setup of the Labfors stirred-tank bioreactor
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roductivity in different culturing containers.
Container type Container Volume Culture Volume Yield mg/L
Fernbach Glass 1.8 L 0.5 L 29
Fernbach Glass 2.8 L 0.8 L 21
Erlenmeyer Glass 5 L 1 L 24
Thomson Optimum Flask 5 L 2 L 25
Wave Bag 10 L 5 L 21
Cooper 38 L 5 L 26
is-mZyx-LIM-eGFP (Lim domain from mouse Zyxin, Uniprot Q62523, fused to eGFP;) was produced for 72 h in Hi5 cells. Protein
as purified by one-step immobilized metal affinity chromatography.
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eGFP Cooper 34 Hi5 96 19 75 25
eGFP Wave 39 Hi5 96 20 84 25
ODC1Cooper 34 Hi5 94 20 70 25
ODC1 Wave 33 Hi5 97 20 77 26
Spd-5 Cooper 83 Sf9 97 21 80 27
Spd-5 Wave 56 Sf9 97 21 87 29
Zyx-LIM-eGFP
Cooper
26 Hi5 93 21 78 27
Zyx-LIM-eGFP
Wave
21 Hi5 93 21 68 26
ells were infected at 1 106 cells/mL. Proteins were produced at 5 L scale for 72 h. All proteins were His tagged and purified by
ne-step immobilized affinity chromatography. ODC1 (Homo sapiens Ornithindecarboxylase, Uniprot P11926; modified); Spd-5
[3],C. elegans, Uniprot P91349).
ig. 2. Coomassie stained SDS-PAGE of proteins produced in Wave and Cooper bioreactors and purified by One-Step
mmobilized Affinity Chromatography. Protein concentration was measured by Bradford staining.
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was discontinued and replaced by Wave Bags. The advantage of Wave-mixed agitation is the efficient
nutrient distribution, off-bottom cell suspension and efficient oxygen transfer without the damaging
shear forces induced by mechanical stirring and gas sparging in stirred-tank bioreactors [6]. There are
a variety of systems commercially available, that differ in bag design, sensor types and type of platform
movement (reviewed in [7]). The mixing is driven by the oscillating movement of a platform and the
mixing rate is controlled by modifying the rocking rate, rocking angle, filling volume and aeration rate
of the shaken bag. With the development of a re-usable Wave-shaken bioreactor1 that can be operated
on these platforms, we exploited all these advantages without increasing our running costs for
consumables. Apart from that cost reduction, some more advantages of our re-usable Wave Bioreactor
were identified during the evaluation process:
1. Despite a filter heating integrated in the Wave system, the air outlet filter of a Wave Bag was
occasionally wetted by condensing water in the tubing and as a consequence, air transfer was
blocked. To circumvent this problem a wide-mouth port covered by a Silicon cap was instead
inserted as air outlet. This guaranteed undisturbed air circulation and also assured sterility.
2. The filling-volume of the box is very flexible in the range of 2–10 L
3. A disposable Wave Bag obtains its shape by filling it with air and the shape is maintained by
constant air circulation. In contrast, the re-usable polycarbonate reactor has a rigid and robust
shape which is insensitive to errors in air exchange like filter wetting.
4. The geometric plane shape together with the grip-like lid facilitates handling especially in
transport.
In summary, this new re-usable bioreactor is most suitable for academic institutions and
productions of low-value products, whereas for high value products, single-use bioreactors will still be
preferred. At the Biochemistry Core Facility of MPIB, this bioreactor enabled the cost-effective upscale
of protein production in insect cells to meet the increasing needs of the users. Todate we have
performed fifty Cooper productions at 2–10 L scale, among them Spd-5 [3] and ATG1 [8], with a
contamination rate of 0,5% and 35 life cycles of the 1st generation Cooper bioreactor.
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